SecBot SecBot
6-K ·Filed Aug 28, 2026

ATHE

ALTERITY THERAPEUTICS LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001437749-26-029129
Notable filing: 6-K
Actionable Insight • Neutral

Monitor next 6-K or 20-F for any material business updates or financial results. This filing is purely administrative and provides no trading signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
ATHE ▼ -22.39% at T+20d
NEUTRAL call -22.39% · α vs SPY -22.90% · entry $4.51 → $3.50
Next anchor: T+60d in 27d
Latest observation: T+39 -56.14% FF3 residual α
Entry = T+0 close
Aug 28, 2026
via day close
T+1d
-0.44%
call -0.44% · α -0.14%
$4.49
settled 8w ago
T+5d
+0.67%
call +0.67% · α +0.56%
$4.54
settled 8w ago
T+20d
-22.39%
call -22.39% · α -22.90%
$3.50
settled 29d ago
T+60d
Pending
in 27d

Price Chart

Loading chart...

Executive Summary

Alterity Therapeutics filed a Form 6-K on August 28, 2026, submitting an application for quotation of securities (ATH) on the Australian Securities Exchange. The filing is a routine administrative step for a foreign private issuer listing additional securities, with no financial data, business updates, or material events disclosed. This is a procedural filing with no immediate stock price impact.

Key Facts

  • Filed Form 6-K on August 28, 2026, for the month of August 2026.
  • Exhibit 99.1 is an application for quotation of securities (ATH) on the Australian Securities Exchange.
  • No financial results, business updates, or material agreements were disclosed in the filing.

Financial Impact

No financial impact disclosed.

Risk Factors

  • No material information provided; stock may trade on existing news flow.
  • Low liquidity on OTC exchange may amplify any future news-driven moves.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001437749-26-029129
Document: 0001437749-26-029129.txt0001437749-26-029129
42 reports for ATHE
Performance horizon
67% Hit rate @ T+60 4 of 6 directional calls Went positive at some point 10 of 10 best @ T+20▲ +27.97%Jun 9, 2026
Filters
Rows
Reports for ATHE — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
6-K
BEARISH ★ 6/10
$2.09awaiting T+60—$2.08 (+0.48%)
Oct 23, 2026
4d ago
6-K
NEUTRAL ★ 2/10
$2.09awaiting T+60—$2.08 (−0.48%)
Oct 23, 2026
4d ago
6-K
NEUTRAL ★ 2/10
$2.09awaiting T+60—$2.08 (−0.48%)
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$2.39awaiting T+60—$2.08 (−12.97%)
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$2.39awaiting T+60—$2.08 (−12.97%)
Oct 19, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$2.43awaiting T+60—$2.08 (−14.40%)
Oct 9, 2026
18d ago
6-K
NEUTRAL ★ 2/10
$3.12awaiting T+60—$2.08 (−33.33%)
Oct 5, 2026
22d ago
Press Release
BULLISH ★ 8/10
$3.22awaiting T+60—$2.08 (−35.40%)
Oct 5, 2026
22d ago
6-K
BULLISH ★ 6/10
$3.22awaiting T+60—$2.08 (−35.40%)
Sep 25, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$3.67awaiting T+60—$2.08 (−43.32%)
Showing 10 of 42

US Market Status

Market Closed — Opens in 1h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 28, 2026